60 generic drugs' efficacy fabricated

On July 7, the Korea Food and Drug Administration (KFDA) unveiled the second results of its ongoing investigation into pharmaceutical testing sites, including bio-venture companies and academic institutions, to check if they forged research data to falsely certify some generic drugs are as effective and safe as their more expensive counterparts.

According to the KFDA, a number of testing sit...